Randomized trial: Convalescent plasma ineffective for patients hospitalized with Covid-19

Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial) – The BMJ

Editorial: Convalescent plasma is ineffective for covid-19 – The BMJ

Commentary on Twitter

Just published @bmj_latest: A randomized trial of convalescent plasma for moderate covidhttps://t.co/dUvEMFSLHG
No benefit. It was underpowered to detect mortality reduction with 464 patients. A large RCT is needed to resolve the question, but these findings are not encouraging. pic.twitter.com/WGtz9IVSZe

— Eric Topol (@EricTopol) October 23, 2020